Holen Sie sich die Stockscreener-App
0.35
3.78%
-0.0138
Renovaro Inc Aktie (RENB) Neueste Nachrichten
Market Watch: Renovaro Inc (RENB)’s Noteworthy Gain, Closing at 0.37 - DWinneX
Investor’s Delight: Renovaro Inc (RENB) Closes Weak at 0.39, Down -16.49 - DWinneX
AI medicine company Renovaro to use Nebul's AI cloud infrastructure - Data Center Dynamics
Renovaro Inc [RENB] stock for 1,448 USD was sold by William Anderson Wittekind - knoxdaily.com
RENB’s 52-Week Rollercoaster: From $0.32 to $2.34 – What’s Next for Investors? - investchronicle.com
Renovaro BioSciences expands collaboration with Nebul - MSN
Insider’s View: Deciphering Renovaro Inc (RENB)’s Financial Health Through Ratios - DWinneX
Renovaro Inc (RENB)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Renovaro Expands Partnership With Nebul To Accelerate AI-Driven Cancer Diagnostics - Nasdaq
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs | RENB Stock News - GuruFocus
Renovaro (ticker) and Nebul Enhance Partnership to Boost Diagnostic Innovations | RENB Stock News - GuruFocus
Renovaro Inc. Expands Collaboration with Nebul to Enhance Early Cancer Detection Through Advanced AI Technology - Nasdaq
Renovaro Secures High-Powered Computing from Nebul Through - GlobeNewswire
Renovaro's New AI Partnership Targets Breakthrough in Early-Stage Lung Cancer Detection Technology - Stock Titan
Renovaro Inc (NASDAQ: RENB) Has Great Upside Potential - Stocksregister
Renovaro faces Nasdaq delisting over share price issue By Investing.com - Investing.com Canada
Renovaro faces Nasdaq delisting over share price issue - Investing.com
Renovaro Inc. (NASDAQ:RENB) Shares Purchased by Corebridge Financial Inc. - Defense World
Renovaro closes merger transaction with BioSymetrics - Pharmaceutical Business review -
Renovaro merges with BioSymetrics to boost AI drug discovery - Investing.com
Renovaro merges with BioSymetrics to boost AI drug discovery By Investing.com - Investing.com South Africa
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven B - GuruFocus
Walmart stands by its annual financial outlook but pulls back its 1Q view amid tariff uncertainty - The Globe and Mail
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - GlobeNewswire
Major AI Breakthrough: Renovaro-BioSymetrics Merger Creates Powerhouse in Precision Medicine - Stock Titan
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and ... - Bluefield Daily Telegraph
Morgan Stanley (MS) Is About to Report Q1 Earnings This Week. Here’s What to Expect - The Globe and Mail
CPKC to report first-quarter 2025 earnings results on April 30 - The Globe and Mail
3 Reasons FDP is Risky and 1 Stock to Buy Instead - The Globe and Mail
2 Reasons to Like AMZN and 1 to Stay Skeptical - The Globe and Mail
Predictive Oncology Ends Merger Talks with Renovaro - TipRanks
RENB: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
Renovaro says Predictive Oncology terminates merger transaction - MSN
RENB stock touches 52-week low at $0.4 amid sharp annual decline - Investing.com Canada
Renovaro Biosciences faces merger setback with Predictive Oncology - Investing.com India
Sector Update: Health Care - marketscreener.com
Health Care Stocks Tumble On Multiple Fronts - Finimize
Renovaro Says Predictive Oncology Terminates Merger Transaction With Co - marketscreener.com
RENB stock touches 52-week low at $0.4 amid sharp annual decline By Investing.com - Investing.com South Africa
Renovaro Biosciences faces merger setback with Predictive Oncology By Investing.com - Investing.com South Africa
Renovaro BioSciences (RENB) Challenges Merger Termination - GuruFocus
Renovaro Biosciences Announces Breach Of Agreement By Predictive Oncology, Legal Action Pending - Nasdaq
Renovaro Says Predictive Oncology Terminates Merger Deal; Shares Fall - MarketScreener
Renovaro Provides Update to Definitive Agreement with Predictive Oncology - GlobeNewswire
3 Quantum Computing Stocks to Buy Now, According to Analysts – 4/2/2025 - The Globe and Mail
Charles Schwab Investment Management Inc. Buys 163,160 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Predictive Oncology pushing forward with Renovaro merger despite $10.8M loss in 2024 - The Business Journals
Predictive Oncology Advances AI Merger Plans Despite $10.8M Loss: Key Strategic Moves Revealed - Stock Titan
1.36%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):